In summary, our studies revealed that gut microbiota metabolites SCFAs constrain the pathogenic potential of gut microbiota antigen specific Th1 cells to maintain intestinal homeostasis and suppress colitis progression through production of IL-10. Here, IL10 is linked to colitis.